Sign in

CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
  1. 4 Other disposition 10% owner disposed of 3,418,692 shares (other)
  2. 4 Other disposition 10% owner disposed of 120,148 shares (other)
  3. 4 Open-market sale 10% owner sold 210,548 shares at $31.25 ($6,579,625)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
  10. 4 Open-market buy 10% owner bought 400,000 shares at $15.00 ($6,000,000)
  11. 4 Open-market buy 10% owner bought 266,667 shares at $15.00 ($4,000,005)
  12. 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
  13. 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
  14. 4 Open-market buy Director bought 266,667 shares at $15.00 ($4,000,005)
  15. 4 Option exercise Director acquired 263,970 shares (option exercise)
  16. 4 Conversion 10% owner acquired 1,600,559 shares (conversion)
  17. 4 Conversion Director acquired 2,506,650 shares (conversion)
  18. 4 Open-market buy Director bought 6,500 shares at $15.00 ($97,500)
  19. 4 Open-market buy Director bought 5,000 shares at $15.00 ($75,000)
  20. 4 Open-market buy VP of Business Dev't bought 500 shares at $15.00 ($7,500)

Page 8 of 9 · 180 filings